Literature DB >> 17117307

Renal stone disease: Causes, evaluation and medical treatment.

Ita Pfeferman Heilberg1, Nestor Schor.   

Abstract

The purpose of the present review is to provide an update about the most common risk factors or medical conditions associated with renal stone formation, the current methods available for metabolic investigation, dietary recommendations and medical treatment. Laboratory investigation of hypercalciuria, hyperuricosuria, hyperoxaluria, cystinuria, hypocitraturia, renal tubular acidosis, urinary tract infection and reduction of urinary volume is based on the results of 24-hr urine collection and a spot urine for urinary sediment, culture and pH. Blood analysis for creatinine, calcium and uric acid must be obtained. Bone mineral density has to be determined mainly among hypercalciurics and primary hyperparathyroidism has to be ruled out. Current knowledge does not support calcium restriction recommendation because it can lead to secondary hyperoxaluria and bone demineralization. Reduction of animal protein and salt intake, higher fluid intake and potassium consumption should be implemented. Medical treatments involve the use of thiazides, allopurinol, potassium citrate or other drugs according to the metabolic disturbances. The correction of those metabolic abnormalities is the basic tool for prevention or reduction of recurrent stone formation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117307     DOI: 10.1590/s0004-27302006000400027

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  11 in total

1.  Medical evaluation and management of urolithiasis.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Ther Adv Urol       Date:  2010-02

2.  Risk factors for nephrolithiasis in children.

Authors:  Banu Acar; F Inci Arikan; Serhat Emeksiz; Yildiz Dallar
Journal:  World J Urol       Date:  2008-09-23       Impact factor: 4.226

3.  An update on metabolic assessment in patients with urinary lithiasis.

Authors:  Carmen Regina Petean Ruiz Amaro; Jose Goldberg; Patricia Capuzzo Damasio; Victor Augusto Leitão; Benjamin Turney; Carlos Roberto Padovani; João Luiz Amaro
Journal:  World J Urol       Date:  2014-03-13       Impact factor: 4.226

4.  Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran.

Authors:  Mohammad Mehdi Hosseini; Ahad Eshraghian; Ilnaz Dehghanian; Dariush Irani; Mitra Amini
Journal:  Int Urol Nephrol       Date:  2009-06-23       Impact factor: 2.370

5.  Renal tubular injury induced by ischemia promotes the formation of calcium oxalate crystals in rats with hyperoxaluria.

Authors:  Yanwei Cao; Wanpeng Liu; Limei Hui; Jianjun Zhao; Xuecheng Yang; Yonghua Wang; Haitao Niu
Journal:  Urolithiasis       Date:  2016-04-04       Impact factor: 3.436

6.  Medical management of renal stone.

Authors:  Shriganesh R Barnela; Sachin S Soni; Sonali S Saboo; Ashish S Bhansali
Journal:  Indian J Endocrinol Metab       Date:  2012-03

7.  Nephrolithiasis: Endocrine evaluation.

Authors:  Salam Ranabir; Manash P Baruah; K Reetu Devi
Journal:  Indian J Endocrinol Metab       Date:  2012-03

Review 8.  Kidney Stone Disease: An Update on Current Concepts.

Authors:  Tilahun Alelign; Beyene Petros
Journal:  Adv Urol       Date:  2018-02-04

9.  Effect of Crystal Shape and Aggregation of Calcium Oxalate Monohydrate on Cellular Toxicity in Renal Epithelial Cells.

Authors:  Xin-Yuan Sun; Meng Xu; Jian-Ming Ouyang
Journal:  ACS Omega       Date:  2017-09-21

10.  Urinary lithiasis: the perfect balance.

Authors:  Fernando Korkes
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.